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Increased left ventricular (LV) mass and changes in LV geometry may precede hypertension onset. The authors
examined the associations of LV mass and geometry, assessed by cardiac magnetic resonance imaging, with
hypertension incidence in 2,567 normotensive participants enrolled in 2000–2002 in the Multi-Ethnic Study of
Atherosclerosis, an ethnically diverse, population-based, US study. Over a median follow-up of 4.8 years, 745
(29%) participants developed hypertension. In a fully adjusted model including baseline blood pressure, the relative
risks of incident hypertension from the lowest to highest LV mass quartile were 1.00 (referent), 1.13 (95% confi-
dence interval (CI): 0.89, 1.43), 1.28 (95%CI: 1.00, 1.63), and 1.78 (95%CI: 1.38, 2.30) (P< 0.001 for linear trend).
Higher levels of LV concentric geometry, defined by higher LV mass to end-diastolic volume quartiles, were
associated with higher risk of incident hypertension in a fully adjusted model (P ¼ 0.044 for linear trend). In a final
model containing both quartiles of LV mass and LV mass/volume along with all covariates including baseline
blood pressure, higher LV mass quartiles were associated with incident hypertension (P < 0.001 for linear trend),
whereas higher LV mass/volume quartiles were not (P ¼ 0.643 for linear trend). In this multiethnic cohort, alter-
ations in LV mass preceded hypertension onset among normotensive individuals.
hypertension; hypertrophy, left ventricular; magnetic resonance imaging; risk factors
Abbreviations: LV, left ventricular; MESA, Multi-Ethnic Study of Atherosclerosis; MRI, magnetic resonance imaging.
Hypertension is associated with markers of cardiovascu-
lar end-organ damage such as left ventricular (LV) hyper-
trophy. As such, LV hypertrophy is often thought to be
a long-standing consequence of hypertension. However,
some evidence suggests that increased LV mass precedes
the onset of hypertension (1–6). Prospective studies have
demonstrated a relation of higher levels of LV mass, as-
sessed by echocardiography, with subsequent increases in
blood pressure (1, 2) or a greater risk of incident hyperten-
sion (3–6) in individuals without hypertension. Thus, alter-
ations in LV mass may contribute to a sustained increase in
blood pressure. Although these data are intriguing, prior
studies have been limited by a small sample size, adjustment
for a limited number of possible confounders, a retrospective
study design, and/or inclusion of a low number of African
Americans and Hispanics, minority groups that have an
increased risk of hypertension. Although 2 relatively large
studies (4–6) have previously examined the relation be-
tween LV mass and incident hypertension, they were pri-
marily restricted to a single ethnic group. One included
white participants from the Framingham Heart and Off-
spring cohorts (4), and the other included American Indians
from the Strong Heart Study (5, 6).
Hypertension is also associated with a spectrum of
LV geometric changes (7, 8). LV concentric geometry—
characterized by increased relative wall thickness (defined
as the ratio of posterior wall thickness to LV radius) with
and without increased LV mass on echocardiography—is
one pattern observed in patients with hypertension (9).
There is limited evidence that this geometric pattern may
be associated with increases in blood pressure prior to the
development of hypertension (1). Thus, in addition to the
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degree of LV mass, an altered LV geometry, characterized
by a concentric pattern, may contribute to hypertension
onset.
Cardiac magnetic resonance imaging (MRI) is a well-
validated methodology for assessment of 3-dimensional
LV mass and geometry (10, 11), and it may allow for more
in-depth investigation of the relation of LV mass and geom-
etry with incident hypertension. We determined whether
increased LV mass and, secondarily, concentric LV geometry,
assessed by cardiac MRI, are associated with hyper-
tension onset in the Multi-Ethnic Study of Atherosclerosis
(MESA), an ethnically and geographically diverse,




Details of the MESA study design have been described
elsewhere (12). Briefly, between July 2000 and August
2002, 6,814 community-dwelling adults aged 45–84 years
and free of clinically evident cardiovascular disease were
enrolled. Participants from 4 race/ethnic groups (white,
African American, Hispanic, and Asian (primarily of Chinese
descent)) were recruited from 6 US communities including
Baltimore, Maryland; Chicago, Illinois; Forsyth County,
North Carolina; Los Angeles County, California; northern
Manhattan, New York; and St. Paul, Minnesota. The study
was approved by the institutional review boards of all sites,
and written informed consent was obtained from all
participants.
Of the 6,814 MESA participants, 5,004 (73%) completed
the cardiac MRI testing at baseline (shortly after examina-
tion 1) and had technically adequate data for analysis. In
addition to examination 1, blood pressure measurements
were performed at subsequent examinations. Blood pressure
data from examinations 1–4 were available for the analyses
presented herein. Of the 5,004 participants with available
cardiac MRI data at examination 1, we excluded those who
had prevalent hypertension at examination 1 as defined be-
low (n¼ 2,315), were missing examination 1 blood pressure
values (n ¼ 1), did not attend at least one follow-up visit
(n¼ 111), and had no blood pressure measurements at follow-
up despite attending the examination (n ¼ 10). Thus, data for
a total of 2,567 participants were available for analysis.
Baseline risk factor measures (examination 1)
Information on demographics, smoking, education, alco-
hol use, physical activity, and medical history were obtained
using standardized questionnaires (12). Educational level
was defined by the highest level achieved. Physical activity
was defined as the total of all light, moderate, and vigorous
activities multiplied by individual metabolic equivalent
values for these activities. Anthropometric measurements
of height and weight were determined with the use of cali-
brated scales. Body mass index was calculated as weight in
kilograms divided by height in meters squared. Total cho-
lesterol, high density lipoprotein cholesterol, triglycerides,
and glucose were measured from blood samples obtained
after a 12-hour overnight fast. The Friedwald equation was
used to calculate low density lipoprotein cholesterol. Dia-
betes was defined as a fasting serum glucose126 mg/dL or
use of hypoglycemic drugs or insulin. Serum creatinine was
measured, and estimated glomerular filtration rate was cal-
culated by the Modification of Diet in Renal Disease equa-
tion. High-sensitivity C-reactive protein was measured
using a particle enhanced immunonepholometric assay on
a BNII nephelometer (Dade-Behring Inc., Newark,
Delaware).
Baseline cardiac MRI
Cardiac MRI using 1.5-T magnets was performed a me-
dian of 16 days after examination 1; 95% of the MRI scans
were completed by 11 weeks after examination 1 (13, 14).
All MRI scans were acquired during short breath-holding at
resting lung volume. A stack of short-axis images covering
the entire left ventricle was acquired with time to repetition/
time to echo as 8–10/3–5 milliseconds, flip angle 20, 6-mm
slice thickness, 4-mm gap, flow compensation, in-plane
resolution 1.4–1.6 mm (frequency) 3 2.2–2.5 mm. Images
were transmitted using the DICOM transfer protocol to the
MESA MRI reading center at Johns Hopkins University.
Image data were analyzed using a semiautomated method
(MASS software, version 4.2; Medis, Leiden, the Netherlands)
by trained readers. The endocardial and epicardial myocar-
dial borders were contoured, and the difference between
the epicardial and endocardial areas for all slices was
multiplied by the slice thickness and section gap and then
multiplied by the specific gravity of myocardium (1.04 g/mL)
to determine LV mass. Papillary muscle mass was included
in the LV volume assessment and was excluded from LV
mass assessment (13, 14). Repeat MRI measurements were
performed on 79 randomly selected participants 3–6 months
after the initial measurement. The technical error of mea-
surement percentages of the mean were 6% and 4% for LV
mass and LV end-diastolic volume, respectively, and the
intraclass correlation coefficients were 0.98 and 0.98,
respectively.
Blood pressure measurements and hypertension
ascertainment (examinations 1–4)
Blood pressure was measured 3 times at 2-minute inter-
vals using an automated oscillometric device (Dinamap
Monitor Pro 100; GE Healthcare, Milwaukee, Wisconsin)
after participants rested for 5 minutes in the seated position.
Appropriate-sized cuffs were utilized for blood pressure
assessment. Blood pressure was defined as the average of
the second and third readings. Participants were asked about
antihypertensive medication use.
Prevalent hypertension was defined by the presence of
any of the following at examination 1: 1) self-reported his-
tory of hypertension, 2) systolic blood pressure 140 mm
Hg or diastolic blood pressure 90 mm Hg, and/or 3) self-
reported use of antihypertensive medication (15). As men-
tioned previously, these participants were excluded from the
current analyses. For participants without hypertension at
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baseline, the incidence of hypertension was defined as the
first follow-up study examination with the presence of 1)
systolic blood pressure 140 mm Hg or diastolic blood
pressure 90 mm Hg, and/or 2) self-reported use of antihy-
pertensive medication (15, 16).
Statistical analyses
The study population was divided into gender-specific
quartiles of LV mass. Characteristics of the population and
hypertension incidence were estimated for each quartile of
LV mass. Unadjusted hypertension incidence rates were
calculated as the number of events in each quartile of LV
mass divided by the sum of person-years at risk. Time at risk
was calculated as the number of days between examinations
1 and 4, unless a participant developed hypertension at an
earlier visit (i.e., examinations 2 or 3) or did not attend
examination 4. For those who developed hypertension, risk
time was calculated as the time between examination 1 and
the first examination at which hypertension was present.
For those who did not attend examination 4, risk time was
calculated as elapsed time from baseline to the last exami-
nation the participant attended (i.e., examination 2 for 74
participants and examination 3 for 84 participants).
Poisson regression was used to calculate the adjusted
relative risks and 95% confidence intervals of hypertension
associated with LV mass. Models with multivariable adjust-
ment for covariates that might be related to LV mass and/or
hypertension were fitted. Consistent with MESA guidelines,
analyses were adjusted for body size by placing height and
weight in the multivariable regression models. In the MESA
study, LV mass indexed by height2.7, which has not been
validated for cardiac MRI, does not fully remove the corre-
lation of this measure with weight or height (17). Models
were also adjusted for additional potential confounders (all
chosen a priori), including MESA site, age, gender, ethnic-
ity, diabetes, cigarette smoking, alcohol use, educational
level, physical activity, estimated glomerular filtration
rate, C-reactive protein, and baseline blood pressure levels.
Linear trends across quartiles were assessed by including
quartile-specific median LV mass values as a continuous
variable in the regression models. Deviation from linearity
was assessed by including a quadratic term for each quartile.
The association between LV hypertrophy and incident hy-
pertension was also examined. LV hypertrophy was defined
as levels greater than the gender-specific 95th percentile for
LV mass (>203.5 g for men and >140.3 g for women),
derived from a MESA reference sample, consisting of 822
participants who were of normal weight, did not have hy-
pertension, and did not have diabetes or impaired fasting
glucose levels (18).
Because angiotensin-converting enzyme inhibitors and
angiotensin II antagonists may have been prescribed to
participants with diabetes but without hypertension, we
conducted sensitivity analyses for participants with and
without diabetes. Additional analyses were conducted
for subgroups defined by age (45–64 years and 65 years),
gender, race/ethnicity, and prehypertension (systolic
blood pressure 120–139 mm Hg or diastolic blood pressure
80–89 mm Hg).
We also examined the relation between LV concentric
geometry, defined as the ratio of LV mass to end-diastolic
volume (13), and incident hypertension. As recommended
by MESA guidelines, parameters of body size were not used
to index LV mass/volume ratio. There are only minor dif-
ferences in the fit between models with LV mass/volume
that adjust and do not adjust for body size (13). Otherwise,
an analytical approach similar to the one used for LV mass
was used. Abnormal LV mass/volume ratio was defined by
levels greater than the gender-specific 95th percentile for LV
mass/volume ratio (>1.47 g/mL for men and >1.29 g/mL
for women), derived from the MESA reference sample (17).
To assess the independent association of LV mass and LV
mass/volume ratio with incident hypertension, both vari-
ables were included in the same regression model. Variance
inflation factors were calculated to examine the possible
existence of multicollinearity among the measures. Statisti-
cal analyses were conducted with SAS 9.2 software (SAS
Institute, Inc., Cary, North Carolina). P values of <0.05
were considered statistically significant.
RESULTS
Participant characteristics
Table 1 shows the baseline characteristics of the sample
across quartiles of LV mass, before and after adjustment for
height and weight. Linear trend for body mass index was not
adjusted for height and weight because body mass index is
estimated from both variables. After adjustment for height
and weight, younger age, female gender, African-American
ethnicity, cigarette smoking, alcohol use, higher levels of
C-reactive protein, and higher levels of systolic blood pres-
sure and pulse pressure were associated with higher levels of
LV mass. Higher levels of body mass index were also asso-
ciated with higher levels of LV mass. In contrast, Chinese
ethnicity, reduced physical activity, and lower estimated
glomerular filtration rate levels were associated with lower
levels of LV mass after adjustment for height and weight.
Relation of LV mass with hypertension incidence
Over a median follow-up of 4.8 years (25th–75th percen-
tiles: 4.5–5.0 years), 745 (29%) of the 2,567 participants
developed hypertension. Higher LV mass quartiles were
significantly associated with higher unadjusted incident hy-
pertension rates (Table 2). This association remained signif-
icant in a fully adjusted model that included baseline blood
pressure. Furthermore, there was no significant deviation
from a linear trend across LV mass quartiles. The relation
between LV mass and incident hypertension was similar
across subgroups defined by age, gender, and race/ethnicity
as well as among participants with and without diabetes and
prehypertension (Figure 1).
The prevalence of LV hypertrophy was 13.1% in the study
population and 52.2% among participants in the highest
quartile of LV mass. In a fully adjusted model, LV hyper-
trophy was significantly associated with incident hyperten-
sion (relative risk ¼ 1.41, 95% confidence interval: 1.15,
1.73; P < 0.001).
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Relation of LV geometry with hypertension incidence
Higher quartiles of LV mass to end-diastolic volume ratio
were associated with significantly higher unadjusted rates of
incident hypertension (Table 3). The linear trend across LV
mass/volume quartiles was also significant in adjusted
models. There was no significant deviation from a linear
trend in unadjusted and adjusted models. In a fully adjusted
model (Table 3, model 3), none of the individual upper 3
LV mass/volume quartiles was significantly associated with
incident hypertension. The prevalence of abnormal LV
mass/volume ratio was 9.2% in the study population. In
a fully adjusted model, the relation between abnormal
LV mass/volume ratio and incident hypertension was not
significant (relative risk ¼ 1.23, 95% confidence interval:
1.00, 1.51; P ¼ 0.051).
After both LV mass quartiles and LV mass/volume quar-
tiles were placed in the same model along with all covariates
including baseline blood pressure, the relative risks of inci-
dent hypertension were 1.00 (referent), 1.13 (95% confidence
interval: 0.89, 1.44), 1.37 (95% confidence interval: 0.99,
1.63), and 1.76 (95% confidence interval: 1.34, 2.30) for
the lowest to highest quartile of LV mass (P < 0.001 for
linear trend). In this model, the relative risks for incident
hypertension associated with the lowest to highest quartile
of LV mass/volume were 1.00 (referent), 1.01 (95% confi-
dence interval: 0.80, 1.28), 0.97 (95% confidence interval:
0.76, 1.23), and 1.04 (95% confidence interval: 0.82, 1.31).
The linear trend across LV mass/volume quartiles was not
significant (P ¼ 0.643). The correlation coefficient of LV
mass with LV mass/volume was 0.44 (P < 0.001). Further-
more, the variance inflation factors for LV mass and LV mass/
volume were 3.20 and 1.46, respectively, indicating no strong
evidence of multicollinearity among the predictors (19).
DISCUSSION
Increased LV mass has been proposed to be a compensatory
response to elevated blood pressure (20). However, evidence
Table 1. Baseline Characteristics of MESA Participants Enrolled in 2000–2002 and Included in the Analysis of Incident Hypertension, by Quartile











Left ventricular mass, g
Women <99.5 99.5–114.2 114.3–130.7 130.8
Men <139.2 139.3–160.7 160.8–183.5 183.6
Mean age (SD), years 60.9 (9.9) 58.5 (9.7) 57.3 (9.1) 56.4 (8.9) <0.001 <0.001
Female gender, % 51.8 51.9 51.9 51.7 0.978 <0.001
Ethnicity, %
White 37.1 45.5 48.4 42.2 0.038 0.193
Chinese American 30.9 16.7 7.2 2.7 <0.001 <0.001
African American 12.2 14.3 19.8 30.8 <0.001 <0.001
Hispanic 19.8 23.5 24.6 24.3 0.051 0.421
Current smoker, % 9.2 12.6 13.9 22.0 <0.001 <0.001
Alcohol user, % 51.3 59.0 68.4 65.0 <0.001 <0.001
High school graduate, % 82.4 84.6 86.3 88.9 <0.001 0.116
Median physical activity (25–75th percentile),
METs-minutes/week
6.7 (4.6–10.1) 7.5 (5.2–10.9) 7.6 (5.3–11.0) 8.2 (5.6–11.7) <0.001 <0.001
Mean body mass index (SD), kg/m2 24.1 (3.7) 26.2 (3.7) 27.5 (4.2) 29.9 (5.0) <0.001 N/A
Median CRP (25–75th percentile), mg/L 1.2 (0.6–2.9) 1.4 (0.6–3.3) 1.5 (0.7–3.4) 1.9 (0.9–4.3) <0.001 0.043
Mean eGFR (SD), mL/minute per 1.73 m2 75.4 (13.7) 75.4 (13.9) 76.2 (14.2) 78.6 (14.7) <0.001 0.009
Reduced eGFRc, % 12.8 11.1 9.2 9.4 0.025 0.074
Microalbuminuria, % 4.2 4.7 5.8 6.9 0.024 0.427
Diabetes, % 4.5 5.3 6.5 6.1 0.147 0.444
Mean systolic blood pressure (SD), mm Hg 111.6 (13.2) 112.8 (12.8) 115.1 (12.7) 117.3 (12.3) <0.001 <0.001
Mean diastolic blood pressure (SD), mm Hg 67.1 (8.6) 68.5 (8.6) 69.7 (8.6) 70.2 (8.5) <0.001 0.790
Pulse pressure (SD), mm Hg 44.5 (10.6) 44.3 (10.4) 45.4 (9.9) 47.1 (10.2) <0.001 <0.001
Abbreviations: CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; MESA, Multi-Ethnic Study of Atherosclerosis; MET, metabolic
equivalent value; N/A, not applicable; SD, standard deviation.
a Unadjusted for body size.
b Adjusted for height and body weight, except for body mass index. Linear trend for body mass index was not adjusted for height and weight
because body mass index is estimated from both variables.
c Defined by an eGFR of <60 mL/minute per 1.73 m2.
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is increasing that LV mass is associated with development of
hypertension (1–6). A few population-based studies (4–6)
have examined whether LV mass is associated with subse-
quent hypertension onset. Post et al. (4) found that, after
adjustment for age, gender, body mass index, alcohol intake,
and blood pressure levels, increased LV mass, assessed by M-
mode echocardiography, predicted hypertension at 4 years of
follow-up in 2,680 normotensive participants in the Framing-
ham Heart Study and Framingham Offspring Study. De
Simone et al. (5) showed that, after controlling for gender,
body mass index, systolic blood pressure, homeostatic model
assessment index, and diabetes, increased LV mass, assessed
by M-mode or linear 2-dimensional echocardiography, was
associated with incident hypertension over 4 years in 777
American Indians from the Strong Heart Study who had op-
timal blood pressure levels (<120/80 mm Hg). De Marco
et al. (6) found a similar independent relation between LV
mass and incident hypertension in 625 prehypertensive par-
ticipants in the Strong Heart Study.
These studies enrolled a low number of African-American
and Hispanic participants and controlled for a limited num-
ber of potential confounders. Our results extend the findings
of these studies by demonstrating that increased LV mass,
assessed by cardiac MRI, is associated with incident hyper-
tension in a large, multiethnic, population-based cohort. This
relation was present after adjustment for several important
confounders. Findings were also consistent across age, gen-
der, and race/ethnicity categories.
In the present study, although the linear trend for incident
hypertension across LV mass/volume quartiles was statisti-
cally significant in a fully adjusted model, none of the upper
3 LV mass/volume quartiles was significantly associated
with incident hypertension. Furthermore, abnormal LV
mass/volume ratio was not significantly associated with
incident hypertension in a fully adjusted model. Iso et al.
(1) found, in normotensive men from a rural community in
Japan, that increased LV mass was more strongly related to
subsequent blood pressure increases in men with smaller LV
chamber dimensions compared with men with larger
LV dimensions, suggesting that LV concentric geometry
may play a role in blood pressure increases. In contrast,
other studies (3, 5, 6) found that LV concentric geometry,
expressed as relative wall thickness, was not associated with
incident hypertension. Reasons for these variable findings
are unknown but may include differences in characteristics
of the study population and in how LV concentric geometry
on echocardiography was defined.
In the present study, in a model that contained both LV
mass and LV mass/volume, the relation between LV mass
quartiles and incident hypertension was unchanged. In
contrast, the magnitude of the relative risks of incident
hypertension associated with the upper 3 LV mass/volume
quartiles became weaker, and the linear trend was no
longer significant. These results suggest that LV concentric
geometry does not contribute to hypertension onset in an
LV-mass-independent manner.





Model 1a Model 2b Model 3c Model 4d
RR 95% CI RR 95% CI RR 95% CI RR 95% CI
Quartile 1 (n ¼ 641) 141 4.8 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref
Women (<99.5 g)
Men (<139.2 g)
Quartile 2 (n ¼ 642) 154 5.3 1.08 0.86, 1.37 1.22 0.96, 1.54 1.22 0.96, 1.55 1.13 0.89, 1.43
Women (99.5–114.2 g)
Men (139.2–160.7 g)
Quartile 3 (n ¼ 642) 182 6.2 1.28 1.01, 1.61 1.52 1.20, 1.94 1.57 1.23, 2.00 1.28 1.00, 1.63
Women (114.3–130.7 g)
Men (160.8–183.5 g)
Quartile 4 (n ¼ 642) 268 9.2 1.82 1.43, 2.31 2.24 1.75, 2.88 2.32 1.80, 3.00 1.78 1.38, 2.30
Women (130.8 g)
Men (183.6 g)
P valuee <0.001 <0.001 <0.001 <0.001 <0.001
P valuef 0.345 0.420 0.762 0.887 0.415
Abbreviations: CI, confidence interval; IR, incidence rate of hypertension (per 100 person-years); MESA, Multi-Ethnic Study of Atherosclerosis;
Ref, referent category; RR, relative risk.
a Model 1 includes adjustment for height, weight, and MESA site.
b Model 2 includes adjustment for variables in model 1 þ age, gender, and ethnicity.
c Model 3 includes adjustment for variables in model 2 þ baseline information on diabetes, smoking, alcohol use, socioeconomic level
(educational level), physical activity, estimated glomerular filtration rate, and C-reactive protein.
d Model 4 includes adjustment for variables in model 3 þ baseline blood pressure levels (systolic and diastolic).
e Represents the linear trend across quartiles (with each quartile represented by the median value within the quartile).
f Represents the deviation from a linear trend across quartiles (with each quartile represented by the median value within the quartile).
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There are several possible explanations for our findings.
The underlying mechanisms responsible for increased LV
mass in the absence of hypertension, and for hypertension
onset, are complex and probably multietiologic. Genetic
factors could play a role in promoting myocardial hypertro-
phy and hypertension onset (21, 22). Extracardiac factors
such as an exaggerated sympathetic drive and a dysregulated
renin-angiotensin-aldosterone system (23), in addition to
vascular structural changes such as arterial stiffness (8),
may also have influenced both LV mass and later hyperten-
sion incidence.
Another explanation is that increased LV mass itself ex-
acerbates the underlying mechanisms responsible for blood
pressure elevation. Early in the course of hypertension, in-
creased LV mass is associated with increased stroke volume,
cardiac output, and central blood volume; later in the dis-
ease process, these parameters fall to normal levels, but
systemic vascular resistance rises (24–26). Thus, in some
individuals, increased LV mass may promote arterial hemo-
dynamic changes in hypertension onset.
Finally, the relation between LV mass and incident hy-
pertension could have been explained by elevated blood
pressure levels at baseline, particularly in the prehyperten-
sion range. The risk of incident hypertension is higher for
individuals with prehypertension than for those with optimal
blood pressure levels (27). Additionally, prehypertension is
also associated with markers of end-organ damage including
increased LV mass (28) and cardiovascular events (29).
However, the fully adjusted model included baseline blood
pressure as a covariate, and the relation between LV mass
and incident hypertension remained significant in this
model. Results were also robust in analyses excluding par-
ticipants with prehypertension, indicating that the indepen-
dent relation between LV mass and incident hypertension is
present even for individuals with optimal blood pressure
levels. These findings are consistent with those reported
by de Simone et al. (5).
Regardless of how LV mass and geometry are related to
the development of hypertension, an argument could be
made to perform imaging such as cardiac MRI or echo-
cardiography to identify nonhypertensive individuals at
risk of hypertension, because the risk for hypertension can-
not be fully explained by demographics and clinical risk
factors (30). However, it is premature to routinely recom-
mend cardiovascular imaging of all hypertension-free
individuals.
There are several limitations to our study. The follow-up
period was relatively short, and blood pressure was mea-
sured at discrete time points during the follow-up period.
Because the results of the cardiac MRI were available to the
MESA participants, it is possible that initiation of antihy-
pertensive medications was influenced by physician knowl-
edge of the degree of LV mass, thereby affecting the
outcome of incident hypertension. However, it is unlikely
that a physician would start antihypertensive medications
for a patient with increased LV mass without first confirm-
ing a diagnosis of hypertension. Furthermore, the relation
between LV mass and incident hypertension was similar
(data not shown) when the outcome was defined solely by
blood pressure levels (140/90 mm Hg). Additionally,
Figure 1. Subgroup analyses of the association between left ventricular mass and incident hypertension for Multi-Ethnic Study of Atherosclerosis
participants enrolled in the study in 2000–2002. P > 0.20 for all interactions. Relative risks (RRs) for the highest quartile versus the lowest quartile
(referent category) are adjusted for height, weight, study site, age, gender, ethnicity, diabetes, smoking, alcohol use, socioeconomic level
(educational level), physical activity, estimated glomerular filtration rate, C-reactive protein, and baseline blood pressure levels (systolic and
diastolic). Prehypertension was defined as a baseline systolic blood pressure of 120–139 mm Hg or a diastolic blood pressure of 80–89 mm
Hg. Each box represents the relative risk, with its size being inversely proportional to its standard error. CI, confidence interval.
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blood pressure readings at baseline were obtained at a single
visit, which may have resulted in inclusion of participants
with prevalent hypertension. However, the results were
not different when we excluded participants with blood
pressures in the prehypertension range. Finally, because
ambulatory blood pressure was not monitored, we cannot
exclude the possibility that some participants with increased
LV mass at baseline had masked hypertension (i.e., normal
office blood pressure and elevated ambulatory blood
pressure).
Strengths of the current study include the use of a large,
multiethnic cohort drawn from several communities in the
United States; the prospective study design; and the careful
and standardized assessment of cardiovascular risk factors,
including blood pressure readings across time. MESA is
also the first large-scale epidemiologic study to use cardiac
MRI to assess LV structure and function in enrolled partic-
ipants (13, 14). Compared with other imaging modalities
such as echocardiography, cardiac MRI has a higher degree
of accuracy and reproducibility for assessing LV mass and
geometry. Thus, MESA offered a unique opportunity to ex-
amine the independent relation of LV mass and LV concen-
tric geometry with incident hypertension.
In summary, higher levels of LV mass and LV hypertro-
phy were significantly associated with a higher risk of in-
cident hypertension for individuals who were initially
normotensive, independent of baseline blood pressure levels
and other explanatory factors. These findings suggest that
the relation between hypertension and alterations in LV
structure may involve more than one directional pathway.
Future studies should confirm these findings and investigate
the factors that increase LV mass in the absence of
hypertension.
ACKNOWLEDGMENTS
Author affiliations: Department of Medicine, Columbia
University Medical Center, New York, New York (Daichi
Shimbo, R. Graham Barr, Steven Shea); Department of
Epidemiology, University of Alabama at Birmingham,
Birmingham, Alabama (Paul Muntner); Department of
Medicine, Mount Sinai School of Medicine, New York,
New York (Devin Mann); Division of Epidemiology and
Community Health, University of Minnesota School of Pub-
lic Health, Minneapolis, Minnesota (Weihong Tang); De-
partment of Medicine, School of Medicine, Johns Hopkins
University, Baltimore, Maryland (Wendy Post, Joao Lima);
Department of Radiology and Radiological Science, School
of Medicine, Johns Hopkins University, Baltimore, Maryland
(Joao Lima); Division of Public Health Sciences, School of
Medicine, Wake Forest University, Winston-Salem, North
Carolina (Gregory Burke); Radiology and Imaging Sciences,
National Institutes of Health, Bethesda, Maryland (David
Bluemke); and Department of Epidemiology, Columbia
University Medical Center, New York, New York (R. Graham
Barr, Steven Shea).





Model 1a Model 2b Model 3c
RR 95% CI RR 95% CI RR 95% CI
Quartile 1 (n ¼ 641) 129 4.3 1.00 Ref 1.00 Ref 1.00 Ref
Women (<0.92 g/mL)
Men (<1.03 g/mL)
Quartile 2 (n ¼ 642) 167 5.7 1.24 0.99, 1.57 1.23 0.97, 1.55 1.08 0.86, 1.37
Women (0.92–1.02 g/mL)
Men (1.03–1.14 g/mL)
Quartile 3 (n ¼ 643) 180 6.1 1.29 1.03, 1.62 1.25 0.99, 1.57 1.07 0.85, 1.34
Women (1.03–1.14 g/mL)
Men (1.15–1.28 g/mL)
Quartile 4 (n ¼ 641) 269 9.5 1.75 1.41, 2.17 1.66 1.34, 2.06 1.24 0.99, 1.55
Women (1.15 g/mL)
Men (1.29 g/mL)
P valued <0.001 <0.001 <0.001 0.044
P valuee 0.634 0.861 0.831 0.710
Abbreviations: CI, confidence interval; IR, incidence rate of hypertension (per 100 person-years); MESA, Multi-Ethnic Study of Atherosclerosis;
Ref, referent category; RR, relative risk.
a Model 1 includes adjustment for age, gender, ethnicity, and MESA site.
b Model 2 includes adjustment for variables in model 1 þ baseline information on diabetes, smoking, alcohol use, socioeconomic level
(educational level), physical activity, estimated glomerular filtration rate, and C-reactive protein.
c Model 3 includes adjustment for variables in model 2 þ baseline blood pressure levels (systolic and diastolic).
d Represents the linear trend across quartiles (with each quartile represented by the median value within the quartile).
e Represents the deviation from a linear trend across quartiles (with each quartile represented by the median value within the quartile).
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